default author photo

Hai Huang

Shanghai Jiao Tong University (SJTU) - Department of Urinary Surgery

197 Ruijin Road No.2

Shanghai, 200025

China

SCHOLARLY PAPERS

1

DOWNLOADS

117

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

Gankyrin is a Novel Biomarker for Disease Progression and Prognosis of Patients with Renal Cell Carcinoma

, EBioMedicine, Volume 39, January 2019, Pages 255-264, https://doi.org/10.1016/j.ebiom.2018.12.011
Number of pages: 48 Posted: 06 Nov 2018
Government of the People's Republic of China - Department of Urinary Surgery, Ningxia Medical University, Government of the People's Republic of China - Department of Urinary Surgery, Government of the People's Republic of China - Department of Urinary Surgery, Shanghai Jiao Tong University (SJTU) - Department of Urinary Surgery, Ningxia Medical University, Ningxia Medical University, Government of the People's Republic of China - Department of Urinary Surgery, Government of the People's Republic of China - Department of Urinary Surgery, Government of the People's Republic of China - Department of Urinary Surgery, Naval Medical University (SMMU), Government of the People's Republic of China - Department of Urinary Surgery, Government of the People's Republic of China - Department of Urinary Surgery, Cornell University - Department of Microbiology and Immunology and Government of the People's Republic of China - Department of Urinary Surgery
Downloads 117 (608,822)

Abstract:

Loading...

Renal cell carcinoma; gankyrin; prognosis; disease progression